PR Newswire TechnologyCodex · 实盘不做把握 8/10
北京时间·🕒 发布 19:30:00时区推断·⟳ 抓取 19:30:59·⚡ 决策 07-13 19:31:28 +29s·106.0 天前
Zimmer Biomet宣布二季度业绩电话会时间，尚未披露业绩内容
这只是业绩电话会和新闻稿发布时间预告，没有披露收入、利润、指引、订单或监管变化。
📄 原文PR Newswire Technology↗ 原文
WARSAW, Ind., July 13, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technolo…
不做 Zimmer Biomet（ZBH.US）
仅为例行财报电话会日程公告，没有方向性信息、金额量级或可验证的短线重定价催化。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-13 · 扩散 low · price-in 风险 low ↗
关键理由
- 这只是业绩电话会和新闻稿发布时间预告，没有披露收入、利润、指引、订单或监管变化。
主要风险
- 若8月5日实际财报披露超预期，需按新事件重新研判。
原文全文
展开原文 · 1,810 字
WARSAW, Ind., July 13, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its second quarter earnings conference call will be webcast on Wednesday, August 5, 2026 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.
A live audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. It will be available for replay following the conference call.
Individuals in the U.S. and Canada who wish to dial into the conference call may do so by dialing (800) 330-6710 and using conference ID 7090861. International callers should dial +1 (213) 279-1505 and use conference ID 7090861.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X at www.x.com/zimmerbiomet.
Contacts:
Media Troy Kirkpatrick 614-284-1926
Kirsten Fallon 781-779-5561 |
Investors David DeMartino 646-531-6115
Zach Weiner 908-591-6955 |
SOURCE Zimmer Biomet Holdings, Inc.
A live audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. It will be available for replay following the conference call.
Individuals in the U.S. and Canada who wish to dial into the conference call may do so by dialing (800) 330-6710 and using conference ID 7090861. International callers should dial +1 (213) 279-1505 and use conference ID 7090861.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X at www.x.com/zimmerbiomet.
Contacts:
Media Troy Kirkpatrick 614-284-1926
Kirsten Fallon 781-779-5561 |
Investors David DeMartino 646-531-6115
Zach Weiner 908-591-6955 |
SOURCE Zimmer Biomet Holdings, Inc.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。